# Lucid Registry Study

> **NCT05965999** · — · UNKNOWN · sponsor: **Lucid Diagnostics, Inc.** · enrollment: 500 (estimated)

## Conditions studied

- Barrett Esophagus
- Esophageal Adenocarcinoma
- Barretts Esophagus With Dysplasia
- Barrett's Esophagus Without Dysplasia

## Interventions

- **DEVICE:** EsoCheck

## Key facts

- **NCT ID:** NCT05965999
- **Lead sponsor:** Lucid Diagnostics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-04-11
- **Primary completion:** 2024-06-01
- **Final completion:** 2024-06-01
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2023-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05965999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05965999, "Lucid Registry Study". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT05965999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*